Acute promyelocytic leukaemia: population-based study of epidemiology and outcome with ATRA and oral-ATO from 1991 to 2021

BACKGROUND: The epidemiology and treatment of acute promyelocytic leukaemia (APL) are changing. We have incorporated oral arsenic trioxide (oral-ATO) into induction/maintenance. METHODS: Newly-diagnosed APL from 1991 to 2021 divided into three 10-year periods were studied to define its epidemiology...

Descripción completa

Detalles Bibliográficos
Autores principales: Gill, Harinder, Raghupathy, Radha, Lee, Carmen Y.Y., Yung, Yammy, Chu, Hiu-Tung, Ni, Michael Y., Xiao, Xiao, Flores, Francis P., Yim, Rita, Lee, Paul, Chin, Lynn, Li, Vivian W.K., Au, Lester, Au, Wing-Yan, Ma, Edmond S.K., Mohan, Diwakar, Kumana, Cyrus Rustam, Kwong, Yok-Lam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9921648/
https://www.ncbi.nlm.nih.gov/pubmed/36765318
http://dx.doi.org/10.1186/s12885-023-10612-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9921648/
https://www.ncbi.nlm.nih.gov/pubmed/36765318
http://dx.doi.org/10.1186/s12885-023-10612-z

Ejemplares similares